Accession |
PRJCA016749 |
Title |
Single-dose, randomized, open-label, two-cycle, cross-over relative bioavailability study of SHR2554 tablets with different processes in healthy subjects |
Relevance |
Medical |
Data types |
clinical,image,Metabolic,Biomarker data
|
Organisms |
Homo sapiens
|
Description |
Single-dose, randomized, open-label, two-cycle, cross-over relative bioavailability study of SHR2554 tablets with different processes in healthy subjects |
Sample scope |
Multiisolate |
Release date |
2023-05-05 |
Grants |
Agency |
program |
Grant ID |
Grant title |
NA
|
|
NA
|
|
|
Submitter |
wanqiu
liang (wanqiu.liang@hengrui.com)
|
Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
Submission date |
2023-05-05 |